Answers are grounded in this paper and cite their sources.
Background: The emergence of multidrug-resistant Citrobacter freundii highlights the need for alternative antimicrobial strategies. Bacteriophages represent a promising solution due to their specificity and ability to lyse target bacteria while sparing the surrounding microbiota. Materials and Methods: Two novel phages, vB_Citrof4 and v B_Citrof5, were isolated and characterized. Their host range, stability, adsorption kinetics on actively growing and dormant cells, and genomic features were assessed. Thermal and copper ion tolerance assays and whole-genome sequencing were performed to evaluate therapeutic potential. Results: Both phages exhibited species-specific lytic activity against select C. freundii strains, with short latent periods (15–20 min) and moderate burst sizes (37–50 PFU/cell). They remained stable under physiological and stress conditions. Adsorption to dormant cells was delayed, and no replication occurred without host activity. Genomes (vB_Citrof4: 178,593 bp; vB_Citrof5: 40,460 bp) contained replication, structural, and lysis modules but lacked lysogeny, toxin, or antibiotic resistance genes. Conclusions: vB_Citrof4 and vB_Citrof5 are strictly lytic, highly specific phages with potential for targeted therapy against actively growing C. freundii .
No takes yet. Share an insight, caveat, or question.
Kamashidze et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: